INSMED Inc
INSM· Nasdaq
INSMINSMED Inc
Filed Feb 17, 2022 · 10-K · 48 days after period end · 0001104506-22-000008
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $56.12M | $41.42M | $45.71M | $9.84M |
| Net Income | -$112.98M | -$102.21M | -$52.99M | -$91.57M |
| EPS Diluted | — | — | -$0.59 | -$1.19 |
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2021 · filed Feb 17, 2022 · 48 d after period end
